{
  "TT6849_syn_1": "Indication: Hx Breast CA, Adenopathy.\nEBUS: 2R, 4R, 7.\nResult: All positive for metastatic breast adenocarcinoma.\nPlan: Oncology for systemic therapy.\nLimit: No PET (CKD).",
  "TT6849_syn_2": "PROCEDURE REPORT: [REDACTED], with a history of breast cancer and CKD, presented for evaluation of mediastinal lymphadenopathy. EBUS-TBNA was performed on stations 2R, 4R, and 7. Rapid on-site evaluation was consistent with metastatic adenocarcinoma of breast origin in all sampled stations. Sedation was titrated carefully due to renal dysfunction. The patient remained stable.",
  "TT6849_syn_3": "Code: 31653 (EBUS 3 stations).\nPathology: Metastatic Breast Cancer.\nStations: 2R, 4R, 7.\nComorbidities: CKD Stage 3 (modified sedation).\nAdequacy: Confirmed.",
  "TT6849_syn_4": "Resident Note\nPatient: [REDACTED]\nProcedure: EBUS\n- History of breast cancer.\n- Sampled 2R, 4R, 7.\n- ROSE showed breast cancer cells.\n- Used lower sedation dose because of kidneys.\n- No issues.",
  "TT6849_syn_5": "sandra lopez 70 female hx breast cancer. kidney disease so no pet scan. did ebus to check lymph nodes. 2r 4r and 7 all looked like cancer on the slide breast origin. reduced fentanyl dose for her kidneys. vitals good. referred back to oncology for chemo.",
  "TT6849_syn_6": "Patient: [REDACTED] | MRN: [REDACTED] | DOB: [REDACTED] PROBLEM LIST: #1 Mediastinal lymphadenopathy - needs tissue diagnosis #2 History of breast cancer (2019) - in remission #3 Chronic kidney disease stage 3 SUBJECTIVE: 70F referred for EBUS evaluation of mediastinal nodes found on surveillance CT. Denies chest pain, hemoptysis, dyspnea. No PET scan performed due to renal dysfunction. OBJECTIVE: Procedure: EBUS-TBNA Sedation: Moderate (midazolam 2mg, fentanyl 50mcg) - limited doses due to CKD... [Rest of text]",
  "TT6849_syn_7": "[Indication]\nMediastinal adenopathy, hx Breast CA.\n[Anesthesia]\nModerate Sedation (Renal dosing).\n[Description]\nEBUS-TBNA 2R, 4R, 7. Metastatic breast CA confirmed.\n[Plan]\nOncology.",
  "TT6849_syn_8": "[REDACTED] a history of breast cancer and kidney disease. We performed an EBUS to check swollen lymph nodes in her chest. We sampled stations 2R, 4R, and 7. Unfortunately, all showed cells consistent with breast cancer returning. We used a lower dose of sedation because of her kidneys, and she tolerated the procedure very well.",
  "TT6849_syn_9": "Patient: [REDACTED]. PROBLEM LIST: Mediastinal lymphadenopathy. History of breast cancer. Chronic kidney disease stage 3. OBJECTIVE: Procedure: EBUS-TBNA. Sedation: Moderate. Findings: Station 2R: sampled x3, ROSE displays metastatic adenocarcinoma. Station 4R: sampled x4, ROSE positive. Station 7: sampled x3, ROSE positive. ASSESSMENT: Metastatic breast cancer verified.",
  "TT6849": "Patient: [REDACTED] | MRN: [REDACTED] | DOB: [REDACTED]\n\nPROBLEM LIST:\n#1 Mediastinal lymphadenopathy - needs tissue diagnosis\n#2 History of breast cancer (2019) - in remission\n#3 Chronic kidney disease stage 3\n\nSUBJECT[REDACTED]: 70F referred for EBUS evaluation of mediastinal nodes found on surveillance CT. Denies chest pain, hemoptysis, dyspnea. No PET scan performed due to renal dysfunction.\n\nOBJECTIVE:\nProcedure: EBUS-TBNA\nSedation: Moderate (midazolam 2mg, fentanyl 50mcg) - limited doses due to CKD\nRamsay: 3\nVitals: Stable throughout, BP 128-142/75-82, SpO2 96-99% on RA\n\nFindings:\n- Station 2R: 8mm, sampled x3, ROSE shows metastatic adenocarcinoma consistent with breast primary\n- Station 4R: 12mm, sampled x4, ROSE positive for metastatic carcinoma\n- Station 7: 9mm, sampled x3, ROSE positive for metastatic carcinoma\n\nSystematic evaluation performed. All accessible stations photographed.\n\nASSESSMENT:\n#1 Mediastinal lymphadenopathy - metastatic breast cancer confirmed\n#2 Breast cancer - recurrent disease, N2/N3 nodal involvement\n#3 CKD - tolerated sedation without issues\n\nPLAN:\n#1 Oncology referral for systemic therapy planning\n#2 Molecular profiling from station 4R sample\n#3 F/u renal function post-procedure\n\nComplications: None"
}
